S Rafi Selected Research

Immune Checkpoint Inhibitors

1/2019

Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Rafi Research Topics

Disease

2	Ulcer 04/2002 - 05/2000
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Suppuration 01/2004
1	Cataract (Cataracts) 04/2003
1	Inflammation (Inflammations) 05/2000

Drug/Important Bio-Agent (IBA)

2	Indomethacin (Indometacin)FDA LinkGeneric 04/2002 - 05/2000
1	Immune Checkpoint InhibitorsIBA 01/2019
1	HydrocarbonsIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	CateninsIBA 01/2019
1	pyrimidineIBA 04/2002
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2002
1	Nabumetone FDA LinkGeneric 04/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2002
1	ProstaglandinsIBA 05/2000
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2000

Therapy/Procedure

1	Therapeutics 01/2019
1	Catheters 01/2004
1	Chest Tubes (Chest Tube) 01/2004
1	Transjugular Intrahepatic Portasystemic Shunt 01/2004
1	Phacoemulsification 04/2003
1	Local Anesthesia 04/2003